Impact of tumor size and sex on diagnostic discrepancies in renal mass imaging

肿瘤大小和性别对肾脏肿块影像诊断差异的影响

阅读:2

Abstract

Renal masses identified on CT or MRI scans may raise suspicion of malignancy, leading to radical or partial nephrectomy; however, pathology reports may reveal benign conditions. This study aimed to identify clinical and radiological factors associated with discrepancies between imaging and pathology reports, which may inform strategies to enhance diagnostic accuracy. We retrospectively reviewed 132 patients who underwent partial or radical nephrectomy between April 2022 and October 2024. All patients underwent preoperative CT, and MRI was conducted when deemed necessary at the physician's discretion. The discrepancy was defined as cases where imaging findings suspicious of malignancy were reported on CT or MRI, but the pathology report later confirmed benign findings. Predictive factors for discrepancies were identified using a multivariate logistic regression model. Of the 132 patients, 98 (74.2%) were diagnosed with renal cell carcinoma (RCC). Among the 31 patients who underwent MRI, 24 (77.4%) were diagnosed with RCC. The discrepancy rate between CT imaging and pathology was 20.6% (27/131). Of these, 7 patients underwent MRI, and in 1 case, the MRI report aligned with the pathology. The overall discrepancy between imaging and pathology was 19.8% (26/131). Multivariable regression analysis revealed that female sex (OR = 5.219, p = 0.001) and a tumor size < 2 cm (OR = 4.826, p = 0.002) were significant factors influencing the discrepancy between imaging and pathology reports. Smaller renal masses (< 2 cm) and female sex were associated with a higher likelihood of diagnostic discrepancy. Considering these factors during imaging interpretation may help reduce overdiagnosis and improve accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。